1. Advances in the diagnosis and prognosis of minimal residual lesions of breast cancer
   Shiyun Cui et al, 2023, Pathology - Research and Practice CrossRef
2. Pan-cancer analysis revealed H3K4me1 at bivalent promoters premarks DNA hypermethylation during tumor development and identified the regulatory role of DNA methylation in relation to histone modifications
   Yang Lu et al, 2023, BMC Genomics CrossRef
3. Peripheral Blood Transcriptome in Breast Cancer Patients as a Source of Less Invasive Immune Biomarkers for Personalized Medicine, and Implications for Triple Negative Breast Cancer
   Helena Čelešnik et al, 2022, Cancers CrossRef
4. Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine
   Andrea Kapinova et al, 2023, EPMA Journal CrossRef
5. An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer
   Sharmilla Devi Jayasingam et al, 2022, International Journal of Molecular Sciences CrossRef
6. Identification of prognostically significant DNA methylation signatures in patients with various breast cancer types
   AI Kalinkin et al, 2022, Bulletin of Russian State Medical University CrossRef
7. Antiproliferative, apoptosis-inducing, and GSTP1 demethylation activities of Ellagitannins isolated from Cornus alba L.
   Siyeon Jin et al, 2023, Natural Product Research CrossRef
8. DNA methylation patterns associated with breast cancer prognosis that are specific to tumor subtype and menopausal status
   Do Hyun Kim et al, 2023, Frontiers in Genetics CrossRef
9. Epigenetic challenges on the horizon of chimeric antigen receptor-T
   Giuditta Benincasa et al, 2024, Cytotherapy CrossRef
10. DNA Methylation Identifies Epigenetic Subtypes of Triple-Negative Breast Cancers With Distinct Clinicopathologic and Molecular Features
    Lawrence Hsu Lin et al, 2023, Modern Pathology CrossRef
11. Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies
    Lenka Trnkova et al, 2024, Biomedicine & Pharmacotherapy CrossRef
12. MicroRNA Expression in Endometrial Cancer: Current Knowledge and Therapeutic Implications
    Irene Iavarone et al, 2024, Medicina CrossRef
13. Increased Risk of Hereditary Prostate Cancer in Italian Families with Hereditary Breast and Ovarian Cancer Syndrome Harboring Mutations in BRCA and in Other Susceptibility Genes
    Giovanna D’Elia et al, 2022, Genes CrossRef
14. Breast cancer detection using volatile compound profiles in exhaled breath via selected ion-flow tube mass spectrometry
    Yoshie Nakayama et al, 2023, Journal of Breath Research CrossRef
15. Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer
    Eva Kudelova et al, 2022, International Journal of Molecular Sciences CrossRef
16. NRF2 signaling pathway: A comprehensive prognostic and gene expression profile analysis in breast cancer
    Negin Soghli et al, 2023, Pathology - Research and Practice CrossRef
17. Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic Response
    Richard Sean Lee et al, 2023, Cancers CrossRef
18. Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation
    Maria Teresa Vietri et al, 2022, Genes CrossRef
19. Big Data in cardiac surgery: real world and perspectives
    Andrea Montisci et al, 2022, Journal of Cardiothoracic Surgery CrossRef
20. Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets
    Luigi Corsaro et al, 2023, Cancers CrossRef
21. Epigenetic Effects of Resveratrol on Oncogenic Signaling in Breast Cancer
    Lucinda Kurzava Kendall et al, 2024, Nutrients CrossRef